Word: hutchinsons
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...fast. It helps keep us on pace; it keeps us relaxed.” Freshman Mark Hirschboeck finished 86th in 27:27, leading the Harvard squad. Kenney was 99th in 27:41, and freshmen Dan Emont and Alex Brenner finished 103rd and 105th, respectively. Another pair of freshmen, Thomas Hutchinson and Robert Schaaf, finished 114th and 141st, respectively, rounding out the Crimson runners. The race was also important for gaining experience on the course, where Harvard will compete again on Oct. 26 in the Heptagonals Championships. The race has left Crimson runners with plenty to think about as they look...
When treating cancer with surgery, it's crucial that every bit of the disease has been removed; but spotting cancer cells left behind after a tumor has been removed is difficult. Now, however, researchers at Seattle's Fred Hutchinson Cancer Research Center have created a molecular "paint" that coats cancer cells so doctors can see the wayward ones that they might otherwise miss...
...Hutchinson's team, led by Dr. Jim Olson, spent three years developing the compound and tested it in a variety of human tumors grown in mice. So far, the researchers have successfully illuminated five kinds of cancers, and they expect to begin testing the agent in human patients next year...
...stand before the bar of justice as equals." Bush's commutation suggests three things: the President believes there is another class of citizen in the U.S., cronyism trumps justice and the President condones perjury and obstruction of justice when it's convenient and helpful to his Administration. Terry Sandquist, HUTCHINSON, MINNESOTA...
...Hutchinson's team, led by Dr. Jim Olson, spent three years developing the compound and has tested it in a variety of human tumors grown in mice. "The target we are hitting is something that most cancer cells use to eat away normal tissue to make space for the cancer to grow," he says. So far the researchers have successfully illuminated five kinds of cancers: gliomas and medulloblastomas in the brain, sarcomas in muscles, and prostate and colon cancers. They expect to begin testing the agent in human patients next year...